Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | TAS2R46 | P59540 | 6/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | PKM | P14618 | 2/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | TERT | O14746 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.34 |
| ▸ | PPARA | Q07869 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.32 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.32 |
| ▸ | CASP1 | P29466 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2905593 | 1.00 | CA1 (0.43) | CA1CA2CA4KMT2ATAS2R46 | |
| SCHEMBL2903613 | 0.88 | TAS2R46 (0.47) | CA1CA2CA4KMT2ATAS2R46 | |
| SCHEMBL2903609 | 0.88 | TAS2R46 (0.47) | CA1CA2CA4KMT2ATAS2R46 | |
| SCHEMBL2902334 | 0.86 | TAS2R46 (0.43) | CA1CA2CA4KMT2ATAS2R46 | |
| SCHEMBL2902335 | 0.86 | TAS2R46 (0.43) | CA1CA2CA4KMT2ATAS2R46 | |
| SCHEMBL2897774 | 0.84 | CA1 (0.43) | CA1CA2CA4KMT2ATAS2R46 | |
| SCHEMBL2897773 | 0.84 | CA1 (0.43) | CA1CA2CA4KMT2ATAS2R46 | |
| SCHEMBL12602390 | 0.72 | CA1 (0.65) | CA1CA2CA4KMT2ACYP3A4 | |
| SCHEMBL1269417 | 0.72 | PTPN1 (0.48) | KMT2ATAS2R46MEN1CNR2PPARA | |
| SCHEMBL1269421 | 0.72 | PTPN1 (0.48) | KMT2ATAS2R46MEN1CNR2PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1838653-B1 | NOVEL TRIMETHYLCYCLODODECATRIENE DERIVATIVES, USE THEREOF, AND PERFUMED PRODUCTS CONTAINING THE SAME | MANE FILS V (FR) | 2010-08-04 | — | — | EP | disclosed |
| US-7737107-B2 | Trimethylcyclododecatriene derivatives, use thereof and perfumed products containing the same | Fils, V. Mane (FR) | 2010-06-15 | — | — | US | disclosed |
| US-20080139446-A1 | Novel Trimethylcyclodoecatriene Derivatives, Use Thereof And Perfumed Products Containing The Same | V. MANE FILS (FR) | 2008-06-12 | — | — | US | disclosed |
| EP-1838653-A1 | NOVEL TRIMETHYLCYCLODODECATRIENE DERIVATIVES, USE THEREOF, AND PERFUMED PRODUCTS CONTAINING THE SAME | V. Mane Fils (FR) | 2007-10-03 | — | — | EP | disclosed |
| WO-2006077306-A1 | NOVEL TRIMETHYLCYCLODODECATRIENE DERIVATIVES, USE THEREOF, AND PERFUMED PRODUCTS CONTAINING THE SAME | V. MANE FILS (FR) | 2006-07-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080139446-A1 | Novel Trimethylcyclodoecatriene Derivatives, Use Thereof And Perfumed Products Containing The Same | CBR3, C5, OXER1 | CA1 3517/4885CA2 3714/4885CA4 3709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.